InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Klichinsky Michael, Chief Scientific Officer. Officer active across 1 company, notably Carisma Therapeutics Inc.. Aggregated, 3 disclosures have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €72k. Activity tracked since 1 October 2025. The latest transaction was disclosed on 1 October 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
165,000 shares@ US$0.25750.0% of flowCommon StockSEC:0001104659-25-096740
165,000 shares@ US$0.25750.0% of flowCommon StockSEC:0001104659-25-096740:0
484,347 sharesCommon StockSEC:0001104659-23-030750:0
3 of 3 declarations
About Klichinsky Michael
Michael Klichinsky is the Chief Scientific Officer at Carisma Therapeutics Inc. He is responsible for overseeing the company's scientific and research initiatives, focusing on the development of new therapies. His expertise in biology and clinical research is essential for Carisma's innovation.
